ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,934Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 910

$574K Total Retail Price of All Prescriptions

Rank: 125 out of 910

303 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 303 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 537 474 1 1
LISINOPRIL 422 347 2 2
FUROSEMIDE 382 351 3 9
GABAPENTIN 290 247 4 13
WARFARIN SODIUM 288 230 5 11
SIMVASTATIN 282 226 6 3
HYDROCODONE-ACETAMINOPHEN 241 210 S3 7 8
DONEPEZIL HCL 207 197 8 32
LOSARTAN POTASSIUM 188 174 9 15
SERTRALINE HCL 187 166 10 24
ATORVASTATIN CALCIUM 169 153 11 14
CLOPIDOGREL 167 149 12 35
AMLODIPINE BESYLATE 151 140 13 4
METOPROLOL SUCCINATE 147 136 14 21
OMEPRAZOLE 146 132 15 5
METOPROLOL TARTRATE 145 127 16 7
NAMENDA 142 139 17 57
OXYCODONE-ACETAMINOPHEN 138 110 S2 18 31
KLOR-CON M20 135 124 19 95
PANTOPRAZOLE SODIUM 132 115 20 27
METFORMIN HCL 132 103 20 6
PLAVIX 131 122 22 53
ATENOLOL 125 102 23 10
CITALOPRAM HBR 120 103 24 19
TRAZODONE HCL 118 99 25 37
PROAIR HFA 116 79 26 40
ZOLPIDEM TARTRATE 111 75 27 17
TAMSULOSIN HCL 109 105 28 29
FINASTERIDE 108 107 29 59
PRAVASTATIN SODIUM 106 106 30 16
FELODIPINE ER 104 92 31 159
SPIRONOLACTONE 88 79 32 66
POTASSIUM CHLORIDE 88 83 32 18
ISOSORBIDE MONONITRATE ER 88 76 32 81
ADVAIR DISKUS 86 73 35 45
CYMBALTA 82 69 36 58
CARVEDILOL 80 69 37 36
CARBIDOPA-LEVODOPA 79 67 38 91
ALLOPURINOL 79 79 38 33
DOXAZOSIN MESYLATE 79 71 38 62
METHADONE HCL 76 43 S2 41 143
LANTUS 72 72 42 30
RISPERIDONE 68 63 43 67
NEXIUM 68 51 43 93
MORPHINE SULFATE ER 62 51 S2 45 52
RANITIDINE HCL 61 49 46 28
VERAPAMIL ER 60 56 47 99
METHYLPREDNISOLONE 60 55 47 122
CRESTOR 60 58 47 26
DIGOXIN 57 57 50 64
AZITHROMYCIN 56 47 51 41
VENLAFAXINE HCL ER 55 31 52 115
HYDROCHLOROTHIAZIDE 52 35 53 12
GLIPIZIDE 51 46 54 38
CLONIDINE HCL 50 43 55 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.